NAD

NAD Recommends Sprint Discontinue ‘New’ Network, Customer Satisfaction Claims, Following T-Mobile Challenge

The NAD has recommended that Sprint Corporation discontinue advertising claims that reference a “brand new,” “all-new” or “America’s Newest” network. Further, NAD has recommended that Sprint discontinue claims that the company “is the most improved U.S. company in customer satisfaction, across all 43 industries, over the last six years.”

Read More

NAD Recommends Genomma Lab Discontinue Challenged Claims in Spanish-Language Ad for Antibiotic Ointment

The NAD has recommended that Genomma Lab USA, Inc., discontinue challenged claims made in Spanish-language broadcast advertising for La Pomada de la Compana triple antibiotic ointment. The claims at issue were challenged by Vitacilina Corporation of America, a competing maker of antibiotic ointment.

Read More

NAD Reviews ‘Compare To’ Claim from B&L, Wal-Mart Following Alcon Challenge

NAD determined that “compare to” claims made by Bausch & Lomb, Inc., and Wal-Mart Stores, Inc., on packaging for “Equate” contact lens products are not comparative performance claims requiring substantiation. Rather, NAD found the challenged language invited consumers to try Equate value products and compare them with brand-name counterparts.

Read More

NAD Examines Claims Made by Weight-Loss Clinic; Slimgenics Modifies Testimonials During NAD Review

The NAD has recommended Slimgenics, LLC, modify or discontinue certain advertising claims for the company’s weight-loss clinic. The claims at issue were challenged by Minnesota Weight Control, a competing weight-loss clinic.

Read More

NAD Finds ThunderWorks can Support Certain Claims for Canine ‘ThunderShirt,’ but Recommends Advertiser Modify Certain Claims

The NAD has recommended that ThunderWorks, LLC, modify or discontinue certain claims related to the company’s “Thundershirt,” a pressure wrap designed to relieve canine anxiety, including claims that “ .. thousands of vets agree – our ThunderShirt is the easiest, safest solution for noise anxiety.”

Read More

NAD Recommends Boehringer Ingelheim Discontinue ‘Maximum Strength’ Claim for DulcoGas Product

The NAD has recommended Boehringer Ingelheim, maker of the anti-flatulence product “DulcoGas Maximum Strength,” discontinue “maximum strength” claims. The labeling claim was challenged by Novartis Consumer Health, Inc.

Read More